Association between immune-inflammatory biomarkers (NLR, PLR, SII, SIRI) and obesity in adults: a systematic review and meta-analysis
- 13 June 2026
- journal article
- review article
- Published by Springer Nature in International Journal of Obesity
- Vol. 50 (7) , 1-18
Abstract
Background Obesity is regarded as a chronic, low-grade systemic inflammatory condition. However, whether immune–inflammatory indices derived from routine peripheral blood tests—including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI)—can accurately reflect obesity-associated inflammation remains controversial, as existing studies have reported inconsistent findings. Comparing these indices between people with obesity and people without obesity, and further evaluating sources of heterogeneity and their potential clinical implications, is of considerable significance for clarifying their role in obesity research and clinical application. Methods Relevant studies published up to September 30, 2025, were systematically searched in PubMed, EMBASE, the Cochrane Library, and Web of Science databases. A meta-analysis was conducted using standardized mean differences (SMDs) to evaluate overall effects, with additional subgroup and sensitivity analyses performed (PROSPERO registration number: CRD420251247523). Results A total of 30 studies were included, comprising 94,408 people with obesity and 129,927 people without obesity as controls. The meta-analysis demonstrated that NLR (SMD = 0.46, 95% CI: 0.10–0.82, p < 0.001), SII (SMD = 2.45, 95% CI: 0.89– 4.01, p < 0.001), and SIRI (SMD = 0.84, 95% CI: 0.47–1.22, p < 0.001) were significantly higher in the group of people with obesity compared with controls, whereas PLR showed no statistically significant difference (SMD = 0.00, 95% CI: −0.08–0.09, p > 0.05). Subgroup analyses indicated that these associations were more prominent in studies defining obesity by BMI, among individuals with chronic comorbidities, and within Asian and American populations. Conclusion NLR, SII, and SIRI may serve as potential low-cost biomarkers reflecting systemic inflammation associated with obesity, while PLR appears to have limited applicability. Future high-quality prospective studies are needed to validate their clinical utility in obesity risk stratification, prediction of complications, and monitoring of therapeutic responses, as well as to explore the potential value of combining these indices with traditional inflammatory and metabolic biomarkers.Keywords
This publication has 88 references indexed in Scilit:
- Assessment of immune function in individuals without and with obesity and normoglycemia, glucose intolerance, or type 2 diabetes: primary findings of the NutrIMM study, a single-arm controlled feeding trialThe American Journal of Clinical Nutrition, 2025
- The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysisClinical and Experimental Medicine, 2025
- Association Between Different Inflammatory Markers and Generalized Abdominal Obesity: A Cross-Sectional StudyObesity Surgery, 2024
- The age‐related obesity paradigm: results from two large prospective cohort studiesJournal of Cachexia, Sarcopenia and Muscle, 2023
- C-Reactive Protein, Neutrophil-to-Lymphocyte Ratio, and Long-Term Mortality in Chinese CentenariansJAMA Network Open, 2023
- TGF-β and inflammatory blood markers in prediction of intraperitoneal adhesionsAdvances in Medical Sciences, 2018
- Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistanceHepatology, 2017
- The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomesJournal of Endocrinological Investigation, 2016
- The mean platelet volume and neutrophil to lymphocyte ratio in obese and lean patients with polycystic ovary syndromeJournal of Endocrinological Investigation, 2015
- The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case–control studyArchives of Gynecology and Obstetrics, 2014